Friday, 3 February 2012- An investigational androgen receptor antagonist substantially boosts survival in castration-resistant prostate cancer, according to phase III trial results.
The oral agent, called MDV3100, improved...
Edited by: JV
Wednesday, 1 February 2012- Treatment with docetaxel in combination with prednisone is the standard first-line treatment in patients with metastatic castration-resistant prostate cancer (mCRPC). For patients failing first-line...
Monday, 30 January 2012- Preoperative MRI helps surgeons make more informed decisions about nerve-sparing procedures in men with prostate cancer, according to a new study published online in the journal Radiology.
Excluding...
Friday, 27 January 2012- H. Aydn and colleagues conducted a study to optimize and predict the most efficient magnetic resonance imaging (MRI) sequences; T1-weighted (T1W), T2-weighted (T2W), dynamic contrast-enhanced (DCE) T1W,...
Wednesday, 25 January 2012- Men with early prostate cancer had significantly less disease progression when treated with dutasteride (Avodart) than with placebo as part of active surveillance, results of a randomized trial showed....
Monday, 23 January 2012- Researchers in Family and Community Medicine at Thomas Jefferson University in the US recently found that obesity was linked to higher rates of prostate cancer (PCa) screening across all races/ethnic...
Wednesday, 18 January 2012- Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy "bait" is a greater challenge. But perhaps such a challenge...
Monday, 16 January 2012- The association between baseline functional status and urinary continence recovery after radical prostatectomy remains controversial. G. Gandaglia and colleagues tested the hypothesis that baseline...
Monday, 16 January 2012- After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly...
Thursday, 12 January 2012- Tuning in to tune out may be just what's needed for men undergoing a prostate biopsy, according to researchers at the Duke Cancer Institute.
The Duke team found that noise-cancelling headphones...
Tuesday, 10 January 2012- Proton therapy, a type of external beam radiation therapy, is a safe and effective treatment for prostate cancer, according to two new studies published in the January issue of the International Journal...
Tuesday, 10 January 2012- The prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial was undertaken to determine whether there is a reduction in prostate cancer mortality from...
Monday, 9 January 2012- H. S. Ahmed and colleagues conducted a study to evaluate the safety, feasibility, side-effect profile, and proof of concept for focal salvage therapy using high-intensity focused ultrasound (HIFU). They...
Wednesday, 4 January 2012- Prostate cancer might have high radiation-fraction sensitivity, implying a therapeutic advantage of hypofractionated treatment.
D. Dearnaley and colleagues conducted a pre-planned preliminary safety...
Tuesday, 3 January 2012- Low serum levels of 1,25(OH)2D3 (1,25D), have been associated with aggressive biologic behavior of prostate cancer (PCa).
In their study, the results of which were published in the journal Anticancer...
Tuesday, 27 December 2011- S. Osanto and H. Van Poppel published a review in an online issue of the journal Therapeutic Advances in Urology examining the development and efficacy of novel treatment options for...
Friday, 23 December 2011- Sipuleucel-T is known to be very well tolerated and to prolong overall survival, but not progression-free survival, measured according to prostate-specific antigen variations and radiographic...
Friday, 23 December 2011- After the US Prostate Cancer Prevention Trial found cancer in many men with low levels of prostate specific antigen (PSA), many debated which PSA level should lead to a biopsy recommendation.
The US...
Tuesday, 20 December 2011- Statins are some of the most commonly prescribed medications in medical practice, and prostate cancer is the most common malignancy among men.
Although there has been no consistent evidence that...
